NDAORALSUSPENSION
Approved
Oct 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Clinical Trials (1)
Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
Started Jun 2013
6 enrolled
Healthy Subjects